- Home
- Publications
- Publication Search
- Publication Details
Title
Sigma receptors and neurological disorders
Authors
Keywords
-
Journal
Pharmacological Reports
Volume -, Issue -, Pages -
Publisher
Springer Science and Business Media LLC
Online
2021-08-05
DOI
10.1007/s43440-021-00310-7
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Sigma-1 receptor agonists as potential protective therapies in multiple sclerosis
- (2020) Robert P. Lisak et al. JOURNAL OF NEUROIMMUNOLOGY
- Sigma-1 and dopamine D2/D3 receptor occupancy of pridopidine in healthy volunteers and patients with Huntington disease: a [18F] fluspidine and [18F] fallypride PET study
- (2020) Igor D. Grachev et al. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
- Sigma-1 Receptor Activation Induces Autophagy and Increases Proteostasis Capacity In Vitro and In Vivo
- (2019) Maximilian Christ et al. Cells
- Targeting the Sigma-1 Receptor via Pridopidine Ameliorates Central Features of ALS Pathology in a SOD1G93A Model
- (2019) Ariel Ionescu et al. Cell Death & Disease
- Pridopidine Induces Functional Neurorestoration Via the Sigma-1 Receptor in a Mouse Model of Parkinson’s Disease
- (2019) Veronica Francardo et al. Neurotherapeutics
- Neuroprotection in non-transgenic and transgenic mouse models of Alzheimer's disease by positive modulation of σ1 receptors
- (2019) Tangui Maurice et al. PHARMACOLOGICAL RESEARCH
- Safety and Efficacy of Edonerpic Maleate for Patients With Mild to Moderate Alzheimer Disease
- (2019) Lon S. Schneider et al. JAMA Neurology
- Pridopidine protects neurons from mutant-huntingtin toxicity via the sigma-1 receptor
- (2019) Chelsy R. Eddings et al. NEUROBIOLOGY OF DISEASE
- Neuronal Sigma-1 Receptors: Signaling Functions and Protective Roles in Neurodegenerative Diseases
- (2019) Daniel A. Ryskamp et al. Frontiers in Neuroscience
- Small-Molecule Modulators of Sigma1 and Sigma2/TMEM97 in the Context of Cancer: Foundational Concepts and Emerging Themes
- (2019) Halley M. Oyer et al. Frontiers in Pharmacology
- Amyloid-β Peptides are Generated in Mitochondria-Associated Endoplasmic Reticulum Membranes
- (2018) Bernadette Schreiner et al. JOURNAL OF ALZHEIMERS DISEASE
- Protective effect of a novel sigma-1 receptor agonist is associated with reduced endoplasmic reticulum stress in stroke male mice
- (2018) Ryuta Morihara et al. JOURNAL OF NEUROSCIENCE RESEARCH
- Sigma-1 receptor and amyotrophic lateral sclerosis
- (2018) Eduardo E. Benarroch NEUROLOGY
- Sigma-1 Receptor-Modulated Neuroinflammation in Neurological Diseases
- (2018) Jia Jia et al. Frontiers in Cellular Neuroscience
- Pridopidine, a clinic-ready compound, reduces 3,4-dihydroxyphenylalanine-induced dyskinesia in Parkinsonian macaques
- (2018) Tom H. Johnston et al. MOVEMENT DISORDERS
- Cholinesterase inhibitor rivastigmine enhances nerve growth factor-induced neurite outgrowth in PC12 cells via sigma-1 and sigma-2 receptors
- (2018) Kazuki Terada et al. PLoS One
- Safety and efficacy of pridopidine in patients with Huntington's disease (PRIDE-HD): a phase 2, randomised, placebo-controlled, multicentre, dose-ranging study
- (2018) Ralf Reilmann et al. LANCET NEUROLOGY
- Pridopidine stabilizes mushroom spines in mouse models of Alzheimer's disease by acting on the sigma-1 receptor
- (2018) Daniel Ryskamp et al. NEUROBIOLOGY OF DISEASE
- Small molecule modulator of sigma 2 receptor is neuroprotective and reduces cognitive deficits and neuroinflammation in experimental models of Alzheimer's disease
- (2017) Bitna Yi et al. JOURNAL OF NEUROCHEMISTRY
- The Sigma-1 Receptor Antagonist, S1RA, Reduces Stroke Damage, Ameliorates Post-Stroke Neurological Deficits and Suppresses the Overexpression of MMP-9
- (2017) Pilar Sánchez-Blázquez et al. MOLECULAR NEUROBIOLOGY
- Sigma-1 receptor knockout increases α-synuclein aggregation and phosphorylation with loss of dopaminergic neurons in substantia nigra
- (2017) Juan Hong et al. NEUROBIOLOGY OF AGING
- The sigma-1 receptor mediates the beneficial effects of pridopidine in a mouse model of Huntington disease
- (2017) Daniel Ryskamp et al. NEUROBIOLOGY OF DISEASE
- Enhanced Bulbar Function in Amyotrophic Lateral Sclerosis: The Nuedexta Treatment Trial
- (2017) Richard Smith et al. Neurotherapeutics
- Protection by sigma-1 receptor agonists is synergic with donepezil, but not with memantine, in a mouse model of amyloid-induced memory impairments
- (2016) Tangui Maurice BEHAVIOURAL BRAIN RESEARCH
- The Sigma-1 Receptor as a Pluripotent Modulator in Living Systems
- (2016) Tsung-Ping Su et al. TRENDS IN PHARMACOLOGICAL SCIENCES
- Sigma-1 receptor is a molecular target for novel neuroprotectant T-817MA
- (2015) Takeaki Yano et al. Alzheimers & Dementia
- Dysfunction in endoplasmic reticulum-mitochondria crosstalk underlies SIGMAR1 loss of function mediated motor neuron degeneration
- (2015) Nathalie Bernard-Marissal et al. BRAIN
- Allosteric modulation of sigma-1 receptors elicits anti-seizure activities
- (2015) Lin Guo et al. BRITISH JOURNAL OF PHARMACOLOGY
- Effect of Dextromethorphan-Quinidine on Agitation in Patients With Alzheimer Disease Dementia
- (2015) Jeffrey L. Cummings et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Pridopidine, a dopamine stabilizer, improves motor performance and shows neuroprotective effects in Huntington disease R6/2 mouse model
- (2015) Ferdinando Squitieri et al. JOURNAL OF CELLULAR AND MOLECULAR MEDICINE
- Role of the Sigma-1 receptor in Amyotrophic Lateral Sclerosis (ALS)
- (2015) Timur A. Mavlyutov et al. JOURNAL OF PHARMACOLOGICAL SCIENCES
- Sigma-1 receptor is involved in degradation of intranuclear inclusions in a cellular model of Huntington's disease
- (2015) Yasuo Miki et al. NEUROBIOLOGY OF DISEASE
- Mitochondrial dysfunction and mitophagy in Parkinson's: from familial to sporadic disease
- (2015) Brent J. Ryan et al. TRENDS IN BIOCHEMICAL SCIENCES
- Mitochondrial protection by the mixed muscarinic/σ1 ligand ANAVEX2-73, a tetrahydrofuran derivative, in Aβ25–35 peptide-injected mice, a nontransgenic Alzheimer’s disease model
- (2015) Valentine Lahmy et al. Frontiers in Cellular Neuroscience
- Pharmacological stimulation of sigma-1 receptors has neurorestorative effects in experimental parkinsonism
- (2014) Veronica Francardo et al. BRAIN
- Effects of dextromethorphan on glial cell function: Proliferation, maturation, and protection from cytotoxic molecules
- (2014) Robert P. Lisak et al. GLIA
- Alzheimer's Therapeutics Targeting Amyloid Beta 1–42 Oligomers II: Sigma-2/PGRMC1 Receptors Mediate Abeta 42 Oligomer Binding and Synaptotoxicity
- (2014) Nicholas J. Izzo et al. PLoS One
- Phase II Trial of the Sigma-1 Receptor Agonist Cutamesine (SA4503) for Recovery Enhancement After Acute Ischemic Stroke
- (2014) Roman Urfer et al. STROKE
- Population-Level Evidence for an Autoimmune Etiology of Epilepsy
- (2014) Mei-Sing Ong et al. JAMA Neurology
- A randomized, double-blind, placebo-controlled trial of pridopidine in Huntington's disease
- (2013) MOVEMENT DISORDERS
- Accumulation of the sigma-1 receptor is common to neuronal nuclear inclusions in various neurodegenerative diseases
- (2013) Yasuo Miki et al. NEUROPATHOLOGY
- SA4503, a sigma-1 receptor agonist, suppresses motor neuron damage in in vitro and in vivo amyotrophic lateral sclerosis models
- (2013) Yoko Ono et al. NEUROSCIENCE LETTERS
- Sigma-1 receptor agonist PRE084 is protective against mutant huntingtin-induced cell degeneration: involvement of calpastatin and the NF-κB pathway
- (2013) A Hyrskyluoto et al. Cell Death & Disease
- The dopamine stabilizers ACR16 and (−)-OSU6162 display nanomolar affinities at the σ-1 receptor
- (2012) K Sahlholm et al. MOLECULAR PSYCHIATRY
- Association between a variant of the sigma-1 receptor gene and Alzheimer's disease
- (2012) Ágnes Fehér et al. NEUROSCIENCE LETTERS
- Sigma-1R Agonist Improves Motor Function and Motoneuron Survival in ALS Mice
- (2012) Renzo Mancuso et al. Neurotherapeutics
- Sigma-1 receptor chaperone and brain-derived neurotrophic factor: Emerging links between cardiovascular disease and depression
- (2012) Kenji Hashimoto PROGRESS IN NEUROBIOLOGY
- The sigma-1 receptor enhances brain plasticity and functional recovery after experimental stroke
- (2011) Karsten Ruscher et al. BRAIN
- Regional Cerebral Glucose Metabolism After Pridopidine (ACR16) Treatment in Patients With Huntington Disease
- (2011) Mouna Esmaeilzadeh et al. CLINICAL NEUROPHARMACOLOGY
- Genetic Polymorphisms in Sigma-1 Receptor and Apolipoprotein E Interact to Influence the Severity of Alzheimers Disease
- (2011) Yue Huang et al. Current Alzheimer Research
- Effects of the selective sigma receptor ligand, 1-(2-phenethyl)piperidine oxalate (AC927), on the behavioral and toxic effects of cocaine
- (2011) Rae R. Matsumoto et al. DRUG AND ALCOHOL DEPENDENCE
- Pridopidine for the treatment of motor function in patients with Huntington's disease (MermaiHD): a phase 3, randomised, double-blind, placebo-controlled trial
- (2011) Justo Garcia de Yebenes et al. LANCET NEUROLOGY
- Low dose dextromethorphan attenuates moderate experimental autoimmune encephalomyelitis by inhibiting NOX2 and reducing peripheral immune cells infiltration in the spinal cord
- (2011) Olga V. Chechneva et al. NEUROBIOLOGY OF DISEASE
- Efficacy and Safety of the Dopaminergic Stabilizer Pridopidine (ACR16) in Patients With Huntington's Disease
- (2010) Anders Lundin et al. CLINICAL NEUROPHARMACOLOGY
- Early development of sigma-receptor ligands
- (2010) Sanju Narayanan et al. Future Medicinal Chemistry
- Role of Presenilins in Neuronal Calcium Homeostasis
- (2010) H. Zhang et al. JOURNAL OF NEUROSCIENCE
- The sigma-1 receptor is enriched in postsynaptic sites of C-terminals in mouse motoneurons. An anatomical and behavioral study
- (2010) T.A. Mavlyutov et al. NEUROSCIENCE
- The sigma-1 receptor chaperone as an inter-organelle signaling modulator
- (2010) Tsung-Ping Su et al. TRENDS IN PHARMACOLOGICAL SCIENCES
- The Hallucinogen N,N-Dimethyltryptamine (DMT) Is an Endogenous Sigma-1 Receptor Regulator
- (2009) D. Fontanilla et al. SCIENCE
- Targeting sigma receptors: novel medication development for drug abuse and addiction
- (2009) Rae R Matsumoto Expert Review of Clinical Pharmacology
- Low density of sigma1 receptors in early Alzheimer’s disease
- (2008) Masahiro Mishina et al. ANNALS OF NUCLEAR MEDICINE
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now